
    
      Participants will undergo screening evaluations to determine their eligibility within 21 days
      prior to the study enrollment.

      Participants will be admitted to the clinical unit a day before administration (day -1) and
      will be confined in the clinical unit until 48 hours after last administration (day 18).
    
  